Shear thinning of Peptide Hydrogels
Shear thinning is usually presented as a convenience feature. A synthetic peptide hydrogel can be pipetted, injected through a fine needle, sprayed onto a surface or extruded through a print nozzle, and it becomes solid again afterwards. That is a genuine advantage over matrices that have to be thermally set or chemically crosslinked, and it is the property that allows the same material to be used in a 96-well plate and in a bioprinter.
It is also a material behaviour with rules, and those rules are not the ones most people assume. The common instinct is to treat a self-assembling peptide hydrogel (SAPH) as fragile: shear breaks the network, so the network should be protected from shear. That model is wrong, and acting on it leads to the wrong handling decisions. These gels are manufactured with a controlled high-shear step, so the material in the vial has already been through far more shear than a pipette or a print nozzle will ever apply, and it is supplied in that state deliberately.
What varies at the bench is therefore not how much shear the gel has seen, but where it is in its recovery when the cells, the microscope or the rheometer arrive.
This article covers what shear thinning actually is in a peptide network, the mechanism behind it, how to measure it in a way that means something, how to estimate the shear a gel experiences in a needle or nozzle, and the handling rules that follow.
Definitions
Shear thinning, yield stress, thixotropy and self-healing are used almost interchangeably in product literature. They describe different measurements and they answer different design questions [1,2].
| Flow properties of a peptide hydrogel, and what each one tells you | |||
| Property | What it describes | How it is measured | What it decides |
| Shear thinning | Apparent viscosity falls as shear rate rises | Flow curve: viscosity against shear rate, across the rates the process actually uses | Whether the gel will pass a given needle or nozzle, and at what pressure |
| Yield stress and flow point | The stress at which the material stops behaving as a solid and begins to flow | Oscillatory amplitude sweep, taking the G' and G'' crossover, or a controlled stress ramp | Whether a deposited filament or droplet holds its shape under its own weight |
| Recovery, thixotropy, self-healing | How much structure returns after shear stops, and how quickly | Three-interval thixotropy test: low strain, high strain, low strain, reporting per cent of G' recovered against time | How long to wait before seeding, imaging or printing the next layer |
| Viscoelasticity (G', G'') | Solid-like against liquid-like response at small deformation | Frequency sweep inside the linear viscoelastic region | The stiffness the cells experience once the material is at rest |
A material can be strongly shear-thinning and still be a poor bioink, because extrudability is set by the first row and shape fidelity by the second and third. Most disappointing print results come from a gel that thins beautifully and then recovers too slowly to hold the filament.
The Mechanism: Fracture, Not Dissolution
A self-assembling peptide gel is a physical network. Beta-sheet nanofibres are held together by hydrogen bonding, hydrophobic interaction and electrostatics, and the fibres are branched and entangled rather than covalently crosslinked [3,4]. The intuitive picture of shear thinning is that shear pulls this network apart into free peptide, which then reassembles when the shear stops.
That is not what happens, and the difference matters. Work on beta-hairpin peptide hydrogels combined rheology with scattering measurements taken during flow, and found the fibrillar structure essentially unchanged at all shear rates studied [5]. Rather than dissolving, the network fractures into gel domains of a few hundred nanometres and larger, which then flow past each other. When shear ceases, those domains percolate back into a continuous network almost immediately, and the material stiffens further over the following minutes as the domain boundaries relax.
Key point: Shear thinning in a peptide gel is fracture and re-percolation, not disassembly and re-assembly. This is why the gel that arrives at the target site is still the same defined material. It is also why recovery has two timescales: an almost immediate return of solid-like behaviour, followed by a slower rise towards the original stiffness.
Two practical consequences follow. First, the same study found that the duration of shear and the strain rate both affected the stiffness recovered immediately after flow and the stiffness eventually reached [5]. Shear history is therefore a real variable, which is an argument for standardising the high-shear steps during manufacture rather than leaving the mechanical starting point of the material to however it happened to set in its container. Second, because the gel is never in solution, anything suspended in it stays suspended in it, which is what makes a preformed peptide gel a credible carrier for cells and particles rather than simply a viscous solution.
Handling: Recovery State, Not Damage
Pipetting a peptide gel into a well applies a shear rate of the same order as some printing operations. So does drawing it into a syringe, mixing in an additive, or dispensing with an automated liquid handler. The instinct is to read this as damage. In a covalently crosslinked gel it would be, because bonds broken by shear do not re-form. In a physical peptide network it is not, because the mechanism is fracture and re-percolation and the nanofibres themselves survive the process.
This is precisely what allows controlled high-shear processing to be used as a manufacturing tool rather than avoided as a hazard. PeptiGel is homogenised during manufacture, which breaks the as-assembled network down into a uniform population of domains and delivers a material with a defined and reproducible starting microstructure, rather than one that depends on how each batch happened to set in its vessel. It is also why the product arrives as a ready-to-use semi-viscous gel with no pH adjustment or thermal setting step required at the bench: the mechanical state has already been standardised upstream, under conditions far more aggressive and far better controlled than anything achievable with a pipette.
Key point: A peptide gel is not harmed by shear in the way a covalent gel is. It is displaced in time. The useful question after any transfer is not whether the material has been damaged, but how far through its recovery it is when the cells, the microscope or the rheometer arrive.
Two things do still vary at the bench, and neither constitutes network damage. The first is the recovery clock: every transfer restarts it, so a gel dispensed and seeded immediately is a softer environment than the same gel given time to rebuild, and two arms of an experiment handled at different tempos are being compared at different points on the recovery curve. The second is air. Vortexing whips bubbles into a viscous gel, and unlike the network, entrained air does not heal. Bubbles scatter light, distort local mechanics and are a common cause of constructs that look inexplicably heterogeneous under the microscope.
Practical guidance: handling a shear-thinning gel reproducibly
The aim is a consistent recovery state, not the avoidance of shear. Use wide-bore tips and slow, steady aspiration, chiefly for accurate volumes and to avoid entraining air rather than to protect the network. After dispensing, allow a defined rest period before seeding, imaging or measuring, and write that period into the protocol as a parameter rather than leaving it to whoever is at the bench. Condition in culture medium as recommended for the variant in use. Where a comparison between conditions matters, put every arm through the same dispensing sequence and the same rest time, controls included. Where an additive has to be mixed in, mix enough to disperse it evenly: under-mixing leaves gradients that are a real problem, while the shear itself is not.
Measuring Shear Thinning
Physical gels are history dependent, so a single parameter is rarely informative. A useful characterisation set includes:
- A flow curve covering the shear rates the process will actually apply, conventionally spanning roughly 0.1 to 1000 reciprocal seconds [2]. Comparing two materials at near-rest conditions can predict the wrong winner, because the ranking of viscosities frequently changes across the shear rate range [1].
- An amplitude sweep to locate the linear viscoelastic region and the flow point, followed by a frequency sweep run inside that region [2].
- A three-interval thixotropy test reporting the percentage of G' recovered at fixed times, for example at 60 seconds and 300 seconds, rather than a qualitative claim of self-healing [7,8].
- The measurement conditions recorded alongside the numbers: peptide concentration, temperature, medium and ionic conditions, geometry and gap, the rest time allowed after loading, and any pre-shear applied.
Two artefacts are worth guarding against. Wall slip flatters shear-thinning materials on smooth plates, so roughened or serrated geometries are preferable. Evaporation stiffens a small sample over the course of a long sweep, so a solvent trap is not optional for anything beyond a quick check [6]. The loading step itself shears the sample, which is exactly why a defined rest period before measurement belongs in the method.
How Much Shear Does the Gel Actually See?
For a cylindrical needle or nozzle, the nominal wall shear rate is 4Q divided by pi R cubed, where Q is the volumetric flow rate and R the internal radius. It is a Newtonian approximation, but it is a useful first estimate and it puts common operations on a common scale. For a strongly shear-thinning material with power-law index n, multiplying by (3n+1)/4n gives a corrected wall value, which roughly doubles the estimate for a gel with n around 0.2.
Extrusion bioprinting through nozzles of around 250 microns typically operates between about 200 and 400 reciprocal seconds [2]. Manual syringe injection is one to two orders of magnitude higher.
Injection: What Actually Damages Cells
The nominal wall shear rate is not the factor that kills cells, and this is the most useful thing to understand about injecting a shear-thinning carrier.
Flow visualisation of beta-hairpin peptide gels in a capillary the width of a fine needle showed a plug flow profile: a wide central region in which the gel and its cell payload move together and experience little or no shear, and a narrow zone close to the wall where deformation is concentrated [9]. A preformed shear-thinning gel therefore shields most of its payload from the shear implied by the bulk flow rate, which a simple viscous carrier does not.
Work on stem cell injection points to the entrance of the needle rather than its length as the main site of acute damage, where extensional flow disrupts membranes [10]. In that study, cells delivered in buffer alone showed markedly lower viability than the same cells delivered in a compliant crosslinked hydrogel, and the protective effect fell away when the carrier was made either stiffer or softer. Protection is a property of the gelled state and of a particular stiffness range, not of the polymer chemistry.
Three practical points follow. Slow the plunger, because flow rate is the variable most directly under the operator's control. Prefer a tapered or conical geometry to a long cylindrical needle where the application allows, since entrance and wall geometry both matter. And measure viability after passage through the actual delivery device rather than inferring it from a bulk culture control.
Printing: The Window Between Extrudable and Self-Supporting
Extrusion bioprinting utilizes two properties that pull against each other. The material has to thin enough to leave the nozzle at a pressure the cells tolerate, and it has to recover fast enough and to a high enough modulus to hold a filament while the next layer arrives.
Shear stress, rather than shear rate, is the quantity most often used as a viability guardrail, with values below roughly 5 kPa associated with high survival in reported microvalve printing work [11]. The practical implication for peptide gels is favourable: because they thin strongly, the stress at the wall stays modest even at printing speeds. The harder constraint is at the other end. Self-assembling peptide gels have relatively modest moduli, so shape fidelity, not extrudability, is usually what limits the achievable geometry.
Two established routes address that. The first is formulating the peptide phase for the printing window directly, which is what the PeptiInk range does. Because it shares the peptide chemistry of PeptiGel, a construct can move from plate culture to printing without changing matrix chemistry, and PeptiInk Alpha 4 PLUS carries the same RGD and GFOGER functionalisation as its PeptiGel counterpart. Synthetic peptide bioinks of this type have supported primary human chondrocytes through two weeks of culture after printing with high viability [12].
The second route is composite formulation: a neutral viscosity modifier such as methylcellulose blended into the peptide phase [13], or a coaxial approach in which a supporting shell stabilises a soft peptide core. Both raise shape fidelity at some cost in defined composition and mesh size, and the trade-offs are set out in our article on composite hydrogels for 3D culture.
Recovery time is the parameter most often overlooked. If the gel needs longer to rebuild than the printer takes to return for the next layer, the construct sags regardless of how well the first layer extruded. That is a rheology measurement, not a printing setting, and it is worth making before optimising the print path.
When Shear Thinning Works Against You
The same behaviour that makes these gels convenient also produces a recognisable set of problems.
| Common symptoms and their rheological cause | ||
| Symptom | Likely cause | What to change |
| Gel looks runny after dispensing and cells settle to the base | Network fractured and not yet re-percolated; recovery clock reset by the last transfer | Add a defined rest period before seeding; reduce the number of transfers; use a wider bore |
| Printed filaments spread and the grid loses definition | Yield stress too low, or recovery too slow relative to print speed | Blend in a viscosity modifier or use a supporting second phase; slow the print; reduce layer height |
| Extrusion is intermittent or the nozzle blocks | Bore too fine for the formulation, or material drying at the tip between passes | Increase bore, prime and purge before each run, and keep the tip covered during pauses |
| Viability drops after injection or printing | Extensional flow at the entrance and wall shear at high flow rate | Reduce flow rate first, then bore and geometry; assess viability after the actual delivery step |
| Stiffness differs between operators or between days | Arms measured or seeded at different points on the recovery curve, because rest times were left to the operator | Fix the dispensing sequence and rest times in the protocol; measure rheology after that same sequence |
| Suspended particles or depots collect at the base of the well | Sedimentation during the recovery window, before the network has rebuilt | Disperse immediately before setting, keep handling brief, and confirm distribution by microscopy at several depths |
The last row in the above table is the one that catches people out when combining a peptide gel with a particulate additive. PODS depot growth factors are denser than the surrounding medium, and a slow recovery leaves most of the depot at the bottom of the well rather than distributed through the construct. The window between dispersing and setting is the whole of the problem, and it is defined by the recovery behaviour of the gel.
Summary
Shear thinning in a peptide hydrogel is fracture of a fibrillar network into domains that flow past each other, followed by re-percolation once the shear stops. The material is chemically and structurally the same before and after, which is what makes it a credible injectable and printable matrix, and what allows a controlled high-shear step in manufacture to deliver a consistent starting point rather than a degraded one. What differs between one sample and another is not damage but timing.
Three rules cover most of the practical consequences. Standardise the rest time rather than trying to avoid shear, because every transfer restarts the recovery clock and any comparison inherits whatever point of the curve each arm was at. Measure at process-relevant shear rates and report recovery as a percentage against time, rather than as a claim. And treat flow rate as the first variable to adjust when viability matters, since it is both the largest lever and the easiest one to control.
Cell Guidance Systems supplies the PeptiGel range of synthetic self-assembling peptide hydrogels across cationic, anionic and neutral chemistries with a range of stiffnesses, and PeptiInk bioinks formulated for extrusion printing on the same chemistry. Background on the material design is on the PeptiGel technology page, and bespoke formulations can be manufactured through the hydrogel production service. For a wider comparison of matrix options, see our guide to choosing a cell culture hydrogel.
References
- [1] Yan C, Pochan DJ. Rheological properties of peptide-based hydrogels for biomedical and other applications. Chem Soc Rev. 2010;39(9):3528-3540.
- [2] Elango J, Zamora-Ledezma C. Rheological, structural, and biological trade-offs in bioink design for 3D bioprinting. Gels. 2025;11(8):659.
- [3] Schneider JP, Pochan DJ, Ozbas B, Rajagopal K, Kretsinger J, Haines L. Responsive hydrogels from the intramolecular folding and self-assembly of a designed peptide. J Am Chem Soc. 2002;124(50):15030-15037.
- [4] Ozbas B, Rajagopal K, Schneider JP, Pochan DJ. Semiflexible chain networks formed via self-assembly of beta-hairpin molecules. Phys Rev Lett. 2004;93(26):268106.
- [5] Yan C, Altunbas A, Yucel T, Nagarkar RP, Schneider JP, Pochan DJ. Injectable solid hydrogel: mechanism of shear-thinning and immediate recovery of injectable beta-hairpin peptide hydrogels. Soft Matter. 2010;6(20):5143-5156.
- [6] Sathaye S, Mbi A, Sonmez C, Chen Y, Blair DL, Schneider JP, Pochan DJ. Rheology of peptide- and protein-based physical hydrogels: are everyday measurements just scratching the surface? WIREs Nanomed Nanobiotechnol. 2015;7(1):34-68.
- [7] Guvendiren M, Lu HD, Burdick JA. Shear-thinning hydrogels for biomedical applications. Soft Matter. 2012;8(2):260-272.
- [8] Loebel C, Rodell CB, Chen MH, Burdick JA. Shear-thinning and self-healing hydrogels as injectable therapeutics and for 3D-printing. Nat Protoc. 2017;12(8):1521-1541.
- [9] Yan C, Mackay ME, Czymmek K, Nagarkar RP, Schneider JP, Pochan DJ. Injectable solid peptide hydrogel as a cell carrier: effects of shear flow on hydrogels and cell payload. Langmuir. 2012;28(14):6076-6087.
- [10] Aguado BA, Mulyasasmita W, Su J, Lampe KJ, Heilshorn SC. Improving viability of stem cells during syringe needle flow through the design of hydrogel cell carriers. Tissue Eng Part A. 2012;18(7-8):806-815.
- [11] Blaeser A, Duarte Campos DF, Puster U, Richtering W, Stevens MM, Fischer H. Controlling shear stress in 3D bioprinting is a key factor to balance printing resolution and stem cell integrity. Adv Healthc Mater. 2016;5(3):326-333.
- [12] Santos-Beato P, Pitsillides AA, Saiani A, Miller AF, Torii R, Kalaskar DM. Evaluation of a synthetic peptide-based bioink (PeptiInk Alpha 1) for in vitro 3D bioprinting of cartilage tissue models. Int J Bioprint. 2023;9(6):0899.
- [13] Cofino C, Perez-Amodio S, Semino CE, Engel E, Mateos-Timoneda MA. Development of a self-assembled peptide/methylcellulose-based bioink for 3D bioprinting. Macromol Mater Eng. 2019;304(11):1900353.
Main Image: Printing PeptiGel. Credit: CellGS
Learn more about EVlution TFF and EV purification tools and protein delivery reagents from Cell Guidance Systems:
